Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q1 EBITDA Rises To SEK 228 Million

April 22 (Reuters) - Vitrolife AB  VITR.ST :
    * INTERIM REPORT JANUARY-MARCH 2022: BUILDING ON OUR STRONG
GROWTH
MOMENTUM
    * Q1 SALES SEK 752 MILLION VERSUS SEK 379 MILLION YEAR AGO
    * Q1 EBITDA  SEK 228 MILLION VERSUS SEK 163 MILLION YEAR AGO

Source text for Eikon:  ID:nWkrbxqqgn 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Vitrolife AB

See all news